Spots Global Cancer Trial Database for autoimmune disease
Every month we try and update this database with for autoimmune disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis | NCT06360861 | Multiple Sclero... Secondary-Progr... Mesenchymal Ste... | Allogenic place... | 17 Years - 45 Years | Tehran University of Medical Sciences | |
| Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer | NCT03816345 | Autoimmune Dise... Crohn Disease Dermatomyositis Hematopoietic a... Inflammatory Bo... Malignant Solid... Multiple Sclero... Psoriasis Psoriatic Arthr... Rheumatoid Arth... Sjogren Syndrom... Systemic Lupus ... Systemic Sclero... Ulcerative Coli... | Biospecimen Col... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis | NCT06384976 | Multiple Sclero... Multiple Sclero... Multiple Sclero... | KYV-101 Standard lympho... Anti-CD20 mAB | 18 Years - 60 Years | Kyverna Therapeutics | |
| Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands | NCT00731536 | Hepatosplenic T... | No intervention | - | Centocor Ortho Biotech Services, L.L.C. | |
| The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing | NCT01280825 | Patients Underg... Heart Diseases Inflammatory Bo... Autoimmune Dise... Inflammatory Di... Blood Coagulati... Hepatitis C Non-Metastatic ... | 18 Years - | University of Chicago | ||
| Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain | NCT01351805 | Autoimmune Dise... Systemic Inflam... Knee Pain Chron... Osteoarthritis Rheumatoid Arth... | Fish Oil Vitamin D placebo pill | 50 Years - | Brigham and Women's Hospital | |
| Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan | NCT03348046 | Rheumatoid Arth... | Biosimilar Infl... | 18 Years - | Hikma Pharmaceuticals LLC | |
| A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia Gravis | NCT06193889 | Myasthenia Grav... Generalized Mya... | KYV-101 Standard lympho... | 18 Years - 75 Years | Kyverna Therapeutics | |
| Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | NCT00716066 | Autoimmune Dise... Neurologic Auto... Autologous Tran... Multiple Sclero... MS Stem Cell Tr... Multiple Sclero... Stiff Person Sy... HCT for Neurolo... CIDP Transplant Myasthenia Grav... Autoimmune Nerv... Central Nervous... Cerebellar Dege... Chronic Inflamm... Lambert Eaton M... Myasthenia Grav... Neuromyelitis O... Opsoclonus Myoc... Rasmussen Subac... | Anti-Thymocyte ... Autologous Hema... Carmustine Cytarabine Etoposide Laboratory Biom... Melphalan Peripheral Bloo... Prednisone Syngeneic Bone ... | - 71 Years | Fred Hutchinson Cancer Center | |
| Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome | NCT00806182 | Opsoclonus-myoc... | 1 Year - 18 Years | National Pediatric Neuroinflammation Organization, Inc. | ||
| Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands | NCT00731536 | Hepatosplenic T... | No intervention | - | Centocor Ortho Biotech Services, L.L.C. | |
| Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | NCT05148806 | Solid Organ Tra... Autoimmune Dise... Haematological ... | self-administer... | 12 Years - | Imperial College London | |
| Serum Auto-Antibodies in Neurological Diseases | NCT00704626 | Multiple Sclero... Myasthenia Grav... Transverse Myel... | Blood Draw Cheek swab | 18 Years - | University of California, Davis | |
| Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome | NCT00466843 | Myelodysplastic... | Antithymocyte g... Prednisone | 18 Years - | Office of Rare Diseases (ORD) | |
| Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis | NCT05451212 | MuSK Myasthenia... | MuSK-CAART | 18 Years - | Cabaletta Bio | |
| Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome | NCT00466843 | Myelodysplastic... | Antithymocyte g... Prednisone | 18 Years - | Office of Rare Diseases (ORD) | |
| A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia Gravis | NCT06193889 | Myasthenia Grav... Generalized Mya... | KYV-101 Standard lympho... | 18 Years - 75 Years | Kyverna Therapeutics | |
| Lab Study of MQX-503 in Treatment of Raynaud's | NCT00253331 | Raynaud Disease Raynaud Disease... Raynaud Seconda... | topical organog... | 18 Years - 80 Years | MediQuest Therapeutics | |
| RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis | NCT06359041 | Generalized Mya... | CABA-201 | 18 Years - 70 Years | Cabaletta Bio | |
| Apremilast Pregnancy Exposure Registry | NCT02775500 | Psoriatic Arthr... Psoriasis | apremilast | - | University of California, San Diego | |
| Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | NCT05148806 | Solid Organ Tra... Autoimmune Dise... Haematological ... | self-administer... | 12 Years - | Imperial College London | |
| Continuation of Follow-up of DES-Exposed Cohorts | NCT00340600 | Breast Cancer Autoimmune Dise... Prostate Cancer Ovarian Cancer Endometrial Can... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
